GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yabao Pharmaceutical Group Co Ltd (SHSE:600351) » Definitions » E10

Yabao Pharmaceutical Group Co (SHSE:600351) E10 : ¥0.23 (As of Sep. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Yabao Pharmaceutical Group Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Yabao Pharmaceutical Group Co's adjusted earnings per share data for the three months ended in Sep. 2024 was ¥0.077. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥0.23 for the trailing ten years ended in Sep. 2024.

During the past 3 years, the average E10 Growth Rate was -2.90% per year. During the past 5 years, the average E10 Growth Rate was -4.20% per year. During the past 10 years, the average E10 Growth Rate was 1.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Yabao Pharmaceutical Group Co was 12.90% per year. The lowest was -6.60% per year. And the median was 3.45% per year.

As of today (2025-04-02), Yabao Pharmaceutical Group Co's current stock price is ¥6.25. Yabao Pharmaceutical Group Co's E10 for the quarter that ended in Sep. 2024 was ¥0.23. Yabao Pharmaceutical Group Co's Shiller PE Ratio of today is 27.17.

During the past 13 years, the highest Shiller PE Ratio of Yabao Pharmaceutical Group Co was 86.14. The lowest was 19.25. And the median was 28.46.


Yabao Pharmaceutical Group Co E10 Historical Data

The historical data trend for Yabao Pharmaceutical Group Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yabao Pharmaceutical Group Co E10 Chart

Yabao Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.25 0.24 0.22 0.22 0.22

Yabao Pharmaceutical Group Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.23 0.22 0.23 0.23 0.23

Competitive Comparison of Yabao Pharmaceutical Group Co's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Yabao Pharmaceutical Group Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yabao Pharmaceutical Group Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Yabao Pharmaceutical Group Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Yabao Pharmaceutical Group Co's Shiller PE Ratio falls into.


;
;

Yabao Pharmaceutical Group Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Yabao Pharmaceutical Group Co's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0.077/115.7848*115.7848
=0.077

Current CPI (Sep. 2024) = 115.7848.

Yabao Pharmaceutical Group Co Quarterly Data

per share eps CPI Adj_EPS
201412 0.049 99.000 0.057
201503 0.100 99.900 0.116
201506 0.105 99.500 0.122
201509 0.094 100.500 0.108
201512 0.022 100.600 0.025
201603 0.090 102.200 0.102
201606 0.023 101.400 0.026
201609 0.026 102.400 0.029
201612 -0.059 102.600 -0.067
201703 0.052 103.200 0.058
201706 0.085 103.100 0.095
201709 0.052 104.100 0.058
201712 0.066 104.500 0.073
201803 0.076 105.300 0.084
201806 0.108 104.900 0.119
201809 0.087 106.600 0.094
201812 0.077 106.500 0.084
201903 0.098 107.700 0.105
201906 0.110 107.700 0.118
201909 0.087 109.800 0.092
201912 -0.274 111.200 -0.285
202003 0.052 112.300 0.054
202006 0.027 110.400 0.028
202009 0.040 111.700 0.041
202012 0.021 111.500 0.022
202103 0.084 112.662 0.086
202106 0.045 111.769 0.047
202109 0.060 112.215 0.062
202112 0.051 113.108 0.052
202203 0.093 114.335 0.094
202206 0.038 114.558 0.038
202209 0.008 115.339 0.008
202212 -0.003 115.116 -0.003
202303 0.140 115.116 0.141
202306 0.079 114.558 0.080
202309 0.059 115.339 0.059
202312 -0.019 114.781 -0.019
202403 0.153 115.227 0.154
202406 0.094 114.781 0.095
202409 0.077 115.785 0.077

Add all the adjusted EPS together and divide 10 will get our e10.


Yabao Pharmaceutical Group Co  (SHSE:600351) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Yabao Pharmaceutical Group Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=6.25/0.23
=27.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Yabao Pharmaceutical Group Co was 86.14. The lowest was 19.25. And the median was 28.46.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Yabao Pharmaceutical Group Co E10 Related Terms

Thank you for viewing the detailed overview of Yabao Pharmaceutical Group Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Yabao Pharmaceutical Group Co Business Description

Traded in Other Exchanges
N/A
Address
No.43 Fumin Road, Ruicheng, Shanxi Province, Yuncheng, CHN, 044602
Yabao Pharmaceutical Group Co Ltd is engaged in the manufacture and operation of western and Chinese medicines, APIs, health care products, packing materials for medicine, and also engages in the planting and processing of medicinal herbs.
Executives
Tang Ke senior management
Zuo Zhe Feng senior management
Xu Zhen Jiang Supervisors
Wang Gang senior management
Ren Peng Bo Director
Ren Wei senior management
Ning Hui Qiang Supervisors
Ren Wu Xian Director

Yabao Pharmaceutical Group Co Headlines

No Headlines